soul trial oral semaglutide cardiovascular outcomes 2024 nejm results and in... : New England Journal of Medicine The impact of oral semaglutide
Description
Clinical trials show semaglutide reduces body weight by 1522% over 68 weeks in patients with obesity or overweight with comorbidities
Keep a pitcher of cucumber water, or add strawberries to your water for an extra boost
In the SURMOUNT-1 trial, the 15 mg dose produced 22.5 percent body weight loss over 72 weeks
Many were encouraged to continue betting even after requesting to be added to self-exclusion lists, or were granted VIP status that included bonuses and incentives despite clear signs of addiction
Once weekly injections offer greater adherence compared to older GLP-1 medications that need to be administered daily
& Lasseter, K
